Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ethopropazine
2. Lysivane
3. Parsidol
4. Parsitan
5. Profenamine
6. Profenamine Hydrochloride
1. Profenamine Hydrochloride
2. 1094-08-2
3. Ethopropazine Hcl
4. Lysivane
5. Pardisol
6. Parfezin
7. Parphezein
8. Dibutil
9. Profenamine Hcl
10. Profenamine Monohydrochloride
11. Isothazine Hydrochloride
12. 10-(2-(diethylamino)propyl)phenothiazine Monohydrochloride
13. Parsidol Hydrochloride
14. Parsidol Monohydrochloride
15. Nsc-64074
16. Nsc-169467
17. O00t1i1vrn
18. Ethopropazine (hydrochloride)
19. N,n-diethyl-alpha-methyl-10h-phenothiazine-10-ethylamine Monohydrochloride
20. Ethopropazine Monohydrochloride
21. Chembl1200970
22. Chebi:31568
23. N,n-diethyl-1-phenothiazin-10-ylpropan-2-amine;hydrochloride
24. 42957-54-0
25. Parphezin
26. N,n-diethyl-1-(10h-phenothiazin-10-yl)propan-2-amine Hydrochloride
27. Dsstox_cid_25347
28. Dsstox_rid_80815
29. Dsstox_gsid_45347
30. Parsidol (van)
31. Lysivane Hydrochloride
32. 10-(2-(diethylamino)propyl)-phenothiazin Hydrochloride
33. Profenamine Hydrochloride (jan)
34. N,n-diethyl-alpha-methyl-10h-phenothiazine-10-ethylamine Hydrochloride
35. Profenamine Hydrochloride [jan]
36. Einecs 214-134-4
37. Nsc 64074
38. Unii-o00t1i1vrn
39. Nsc 169467
40. Sr-05000001626
41. Prophenamine Hydrochloride
42. 10h-phenothiazine-10-ethanamine,n-diethyl-.alpha.-methyl-, Monohydrochloride
43. Ethopropazine Hydrochloride [usp]
44. Parsidol (tn)
45. Prestwick_195
46. Einecs 256-019-1
47. L-10-(2-diethylaminopropyl)phenothiazine Hydrochloride
48. Ncgc00016562-01
49. 10-phenothiazineethylamine, N,n-diethyl-alpha-methyl-, Hydrochloride
50. Cas-1094-08-2
51. Schembl123703
52. Spectrum1500293
53. Dtxsid4045347
54. Hms1570h21
55. Hms1920o04
56. Pharmakon1600-01500293
57. Bcp12225
58. Nsc64074
59. Phenothiazine, 10-(2-(diethylamino)propyl)-, Monohydrochloride
60. Tox21_110496
61. Tox21_500873
62. Ccg-40202
63. Nsc169467
64. Nsc757029
65. 10h-phenothiazine-10-ethanamine, N,n-diethyl-alpha-methyl-, Monohydrochloride
66. Akos015901042
67. Tox21_110496_1
68. Lp00873
69. Nsc-757029
70. Ethopropazine Hydrochloride [mi]
71. Ncgc00094678-01
72. Ncgc00094678-02
73. Ncgc00178860-06
74. Ncgc00261558-01
75. Profenamine Hydrochloride [mart.]
76. Profenamine Hydrochloride [who-dd]
77. Ethopropazine Hydrochloride [vandf]
78. Db-040867
79. Hy-107922
80. Cs-0030870
81. Ft-0625740
82. D01118
83. Ethopropazine Hydrochloride [orange Book]
84. Ethopropazine Hydrochloride, >=98% (hplc), Powder
85. Sr-05000001626-2
86. Q27114444
87. 10h-phenothiazine-10-ethanamine,n,n-diethyl-a-methyl-,hydrochloride(1:1)
88. 10h-phenothiazine-10-ethanamine, N,n-diethyl-.alpha.-methyl-, Hydrochloride (1:1)
89. Ethopropazine Hydrochloride;profenamine Hcl; Ethopropazine Hcl; 10-[2-diethylaminopropyl]phenothiazine
Molecular Weight | 348.9 g/mol |
---|---|
Molecular Formula | C19H25ClN2S |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 5 |
Exact Mass | 348.1426977 g/mol |
Monoisotopic Mass | 348.1426977 g/mol |
Topological Polar Surface Area | 31.8 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 322 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
Adrenergic Antagonists
Drugs that bind to but do not activate ADRENERGIC RECEPTORS. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters EPINEPHRINE and NOREPINEPHRINE. (See all compounds classified as Adrenergic Antagonists.)
Histamine Antagonists
Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)
ABOUT THIS PAGE
A Profenamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Profenamine, including repackagers and relabelers. The FDA regulates Profenamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Profenamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Profenamine supplier is an individual or a company that provides Profenamine active pharmaceutical ingredient (API) or Profenamine finished formulations upon request. The Profenamine suppliers may include Profenamine API manufacturers, exporters, distributors and traders.
click here to find a list of Profenamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Profenamine DMF (Drug Master File) is a document detailing the whole manufacturing process of Profenamine active pharmaceutical ingredient (API) in detail. Different forms of Profenamine DMFs exist exist since differing nations have different regulations, such as Profenamine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Profenamine DMF submitted to regulatory agencies in the US is known as a USDMF. Profenamine USDMF includes data on Profenamine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Profenamine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Profenamine suppliers with USDMF on PharmaCompass.
Profenamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Profenamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Profenamine GMP manufacturer or Profenamine GMP API supplier for your needs.
A Profenamine CoA (Certificate of Analysis) is a formal document that attests to Profenamine's compliance with Profenamine specifications and serves as a tool for batch-level quality control.
Profenamine CoA mostly includes findings from lab analyses of a specific batch. For each Profenamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Profenamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Profenamine EP), Profenamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Profenamine USP).
LOOKING FOR A SUPPLIER?